Navigation Links
Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
Date:6/12/2009

CHAPEL HILL, N.C., June 12 /PRNewswire/ -- Two-thirds of companies find that a vertical quality and compliance model effectively increases internal efficiencies compared to a horizontal model. However, according to a recent study by Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL, having a single Q&C organization per function does not help reduce operating costs, an increasingly important challenge in today's economic landscape.

How efficient and effective are quality and compliance processes at your company?

Download a complimentary research briefing at http://www3.best-in-class.com/gr193.htm to view key study objectives, a list of benchmarked companies, selected key findings, commonly used quality and compliance management structures and their effectiveness, reorganization trends and more. This partner-driven primary research is an example of how we support quality executives with relevant metrics and best practices for strategic decision-making.

Recently Added Research for Partners include:

  • The Role of Regulatory Affairs in Preparing for NDA Interactions
  • Best Practices for Valuing Internal Consulting Organizations
  • M&A Integration Excellence: What Bio-Pharma Companies Need to Know
  • Skills, Capabilities and Competencies for Success in Regulatory Affairs
  • Safety and Risk Management in the Pharmaceutical Sector

Discuss your specific business dilemmas in a Guided Virtual Presentation of our decision support services with Elizabeth Winstead, director of solutions. Please sign up now at http://www3.best-in-class.com/gr179.htm to explore further the suite of research and networking opportunities available to you through a business partnership with the GLOBAL BENCHMARKING COUNCIL. For more information, contact her directly at 919.767.9259, ewinstead@best-in-class.com.

Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL (http://www3.best-in-class.com/gbc) is an innovative research, benchmarking and networking service for business executives in pharmaceutical and life sciences to promote top-line revenue growth, cost reduction and innovative problem-solving.

For more than a decade, executives have used GLOBAL BENCHMARKING COUNCIL competitive advantages, such as ready access to executives, fast-turnaround research efforts, expansive Best Practice Database and annual networking conferences to refine initiatives, request funding and allocate resources.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 19, 2017 , ... A July 5th ... weight loss surgery patients who had received a body contouring procedure reported experiencing a ... clinic Beverly Hills Physicians (BHP), which provides both types of procedures, notes that this ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Fidget”: a fun-filled, action-packed ... retired public high school music and drama teacher who was a summa cum laude ... including a “Teacher of the Year” award. After her retirement from public school, Lynn ...
(Date:7/18/2017)... Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking place ... will be speaking on the therapeutic benefits of medical cannabis for both pediatric and ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov ... Decisions Do You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — ... Part 11, “Final Rule for Clinical Trials Registration and Results Information,” is a ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... ... on a lien basis, partners with the best medical professionals who offer the ... and pre-approves each medical professional in their network, ensuring that each patient receives ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Zymo Research Corp., also known as ,The Epigenetics Company, announced ... in a precise manner using the myDNAge ™ test. Based on ... of human genetics and biostatistics at the David Geffen School of ... Zymo Research,s proprietary DNAge ™ technology is used to analyze DNA ... ...
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a ... who suffer from painful intercourse and other painful pelvic pain conditions such ... to menopause. ... LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void ...
Breaking Medicine Technology: